Navigation Links
IsoSleeve™ Source Delivery System

ProductsIsoSleeve™ Source Delivery System
Company C. R. Bard, Inc.
Item IsoSleeve™ Source Delivery System
Features 
  • Provided Sterile: Pre-loaded IsoSleeve™ needles are sterile and ready to use.
  • Pre-Loaded Needles: Each needle arrives custom loaded thereby decreasing pre-treatment preparation.
  • Ready To Use: Upon receipt, the product configuration allows for immediate use.
  • Reduce Handling: Spares unnecessary radiation exposure to clinical personnel.
  • Prevents Movement: Unique product design prevents movement of seeds and spacers until desired.
  • Tactile Feedback: Patented design feature allows for release verification of seeds and spacers.
  • Confirm Loading Pattern: The IsoSleeve™ delivery system design allows for easy viewing of seed and spacer pattern
  • Needle Labeling: Each IsoSleeve™ hub is labeled per the treatment plan.
  • Verification Photograph: With each shipment, a photographic record is provided of all loaded sleeves with labels documenting seed and spacer
  • Custom Loaded - patient Specific: Each custom-loaded needle corresponds directly to the patients treatment plan.
  • Needle Loading Pattern: Each needle can hold up to 7 seeds and 7 spacers.
  • Pre-Loaded Needle: IsoSleeve™ needle and obturator are shipped assembled and ready to use.
Description The IsoSleeve™ Source Delivery System incorporates a translucent inner sleeve into a proprietary design that provides the confidence that each needle load matches the proper load configuration prior to implant. Unlike other preloaded needle options, the IsoSleeve™ system allows for visual verification of the loading configuration giving you confidence that the needle load is correct. The IsoSleeve™ Source Delivery System is custom loaded for each patient and is delivered in a convenient package that allows an easy transfer to the sterile field for immediate use. With each order, Bard Brachytherapy provides a photographic record of each needle load, providing the confidence of knowing the location of each source.
Info C. R. Bard, Inc.
Customer Service: (800) 367-2273
Web site: http://www.crbard.com

Related medicine products :

1. Micro-Mini Fiber Optic Light - Source 100
2. 300XL Xenon Light Source
3. Xenon XL Light Source
4. Xenon Light Source
5. Xenon Light Source 175W With Turret
6. Storz 150W Light Source With Turret
7. Welch Allyn Wall/Desk Power Source for Binocular Indirect Ophthalmoscope
8. LX - Mini Light Source (Metal Halide) 25 Watt
9. AL1 180W Xenon Light Source
10. 8430W 300 Watt Xenon Light Source
11. 150 watt Halogen Light Source
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products:
(Date:4/24/2014)... first identified more than 15 years ago, the PTEN ... in preventing the onset and progression of numerous cancers. ... cells can grow unchecked and cancer can develop. , ... Deaconess Medical Center (BIDMC) helps explain more precisely how ... or alteration can set cells on a cancerous course. ...
(Date:4/24/2014)... Benefits often coexist with the negative and stressful outcomes ... later diagnosed with a life-limiting illness, says a recent ... Waterloo. , While the challenges are numerous and life-changing ... who participated in the Waterloo-led research reported positive outcomes ... findings appear in the most recent issue of the ...
(Date:4/24/2014)... Center for BrainHealth will bring together national experts ... challenges at its inaugural Brain Health Summit, titled ... speakers will include Dr. Sandra Bond Chapman, founder ... U.S. Senator Chuck Grassley (R-IA), U.S. Representative Chaka ... for Policy and Early Learning, U.S. Department of ...
(Date:4/24/2014)... epidemic of prescription opioid overdose deaths was outlined yesterday ... by leaders of agencies in the U.S. Department of ... health care providers to expand their use of medications ... describes a number of misperceptions that have limited access ... how medications can be used in combination with behavior ...
(Date:4/24/2014)... 4/24/14) Dartmouth has been awarded one of 30 ... as a Lead Academic Participating Site in its new ... recipients are a select groups of investigators charged with ... cooperative groups., The NCTN grant system reflects recommendations from ... streamlines operations to achieve four goals:, Faster ...
Breaking Medicine News(10 mins):Health News:Surprising new insights into the PTEN tumor suppressor gene 2Health News:Surprising new insights into the PTEN tumor suppressor gene 3Health News:Parents of severely ill children see benefits as caregivers, says study 2Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3
... The University of Texas M. D. Anderson Cancer Center ... significant role in determining// the aggressiveness of prostrate cancer. ... October 1 issue of Clinical Cancer Research, corroborates findings ... the development of prostate cancer. Sara Strom, Ph.D., an ...
... insulin therapy is the recommended method of diabetes management ... still want of an intravenous insulin protocol that is ... and simple enough to be used throughout the hospital ... Diabetes Associates, Georgia, led by Paul C. Davidson has ...
... Phase II study to 12 months confirm the significant effects ... patients with relapsing multiple sclerosis (MS). ,The data, ... both patient groups taking FTY720 (1.25 mg and 5 mg) ... of more than 50% during the first six months of ...
... In a path-breaking surgery here, an elderly woman suffering ... was relieved of the diseased parts without any trauma ... led by B. Ramana performed the two-hour-long operation - ... breast approach at Apollo Gleneagles Clinic last week. ...
... a chronic illness that requires continuing medical care ... and to reduce the risk of long-term complications//. ... primary care practitioners are confronted with an ever-increasing ... nephropathy. Undiagnosed chronic kidney disease (CKD) is common ...
... from Barts and London Queen Mary’s School of Medicine, ... microarray to find the gene which is probably responsible ... gene which on mutations leads to Basal cell carcinoma, ... in 60,000 patients each year, causing 500 deaths yearly. ...
Cached Medicine News:Health News:Novartis MS Drug Shows Promising Results 2Health News:Novartis MS Drug Shows Promising Results 3Health News:Endoscopic Thyroidectomy Helps In Removing Thyroid Cysts 2
(Date:1/14/2014)... , Jan. 14, 2014 NineSigma , Inc., ... its Innovation Leadership Summit , May 14-16, 2014 ... Cleveland Ohio . This ... organizations committed to breakthrough achievements through open innovation. Participants ...
(Date:1/14/2014)... , January 14, 2014 Equashield ... for hazardous drugs, today announced that it has ... straight year.   Equashield,s closed systems ... pharmacists, nurses and other medical professionals who prepare ...
(Date:1/14/2014)... , Jan. 14, 2014 Spark Therapeutics , a late-stage ... most advanced clinical program, a Phase 3 study for inherited retinal ... CEO, Jeffrey D. Marrazzo , is presenting this and other ... in San Francisco . Marrazzo said Spark was ...
Breaking Medicine Technology:Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 3